San Francisco start-up BlackThorn aims to combine cloud- and AI-based data collection tool PathFinder with brain imaging technology and behavioural evaluation techniques in a "targeted, predictive approach" to finding suitable patients for clinical trials. Blackthorn recently raised $$76 millionm in a series B round to fund human trials of treatments for mood or anxiety disorders and autism. It aims to increase the level of precision in establishing a drug's effectiveness.
San Francisco start-up BlackThorn aims to combine cloud- and AI-based data collection tool PathFinder with brain imaging technology and behavioural evaluation techniques in a "targeted, predictive approach" to finding suitable patients for clinical trials. Blackthorn recently raised $76m in a series B round to fund human trials of treatments for mood or anxiety disorders and autism. It aims to increase the level of precision in establishing a drug's effectiveness.